TRAIL VARIANTS FOR TREATING CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110165265A1
SERIAL NO

12808595

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of a mutant TRAIL protein to treat various cancers in mammals. The invention provides a variant TRAIL protein, which has superior selectivity for the death receptor 5, for treating a mammal diagnosed with cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ACADEMISCH ZIEKENHUIS GRONINGEN;NATIONAL UNIVERSITY OF IRELAND, GALWAY;RIJKSUNIVERSITEIT GRONINGEN;FUNDACIÓ GENÒMICA (CRG);INSTITUCIO CATALANA DE RECERCA I ESTUDIS AVANCATS (ICREA)

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Samali, Afshin Galway, IE 7 25

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation